|

Blood sampling Clinical Trials

18 actively recruiting trials

No change since May 2026

Also known as: Tumor sampling

Pipeline

Early 1: 1

Top Sponsors

  • University Hospital, Toulouse3
  • Hospices Civils de Lyon3
  • Centre Hospitalier Universitaire Dijon3
  • Assistance Publique - Hôpitaux de Paris2
  • University Hospital, Clermont-Ferrand1

Indications

Other18 trials

Analysis of Circulating Tumor Markers in Blood
N/A
B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.
Early 1
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.
N/A
Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer
N/A
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls
N/A
Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity
N/A
Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)
N/A
Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
N/A
Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques
N/A
Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
N/A
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
N/A
Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer
The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).
cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.